Vermont Governor Peter Shumlin announced Monday the state will set up DUI courts to reduce the number of repeat drunk drivers. The courts will operate much like the three drug courts in the state, according to the Associated Press.
Category results for "Government"
New Mexico’s largest jail will no longer use methadone to treat inmates who are addicted to drugs, The New York Times reports. The jail’s warden cited cost concerns. He also questioned the program’s effectiveness.
As smoke-free housing policies gain momentum, we should ensure populations that are disproportionately impacted by tobacco use are considered, says David Dobbins of Legacy.
The Drug Enforcement Administration has proposed new regulations to give the public more options for disposing of unwanted prescription drugs, such as painkillers and sedatives.
Drug companies that manufacture the painkillers OxyContin and Opana are trying to block generic drug makers’ efforts to produce cheaper versions of the drugs. They argue these newer drugs will not have the tamper-resistant designs used in making the brand-name pills, according to The New York Times.
Energy drinks, under investigation by the Food and Drug Administration after reports of deaths and serious injuries, offer little or no benefit to consumers, experts say.
People who use marijuana in Colorado and Washington state, which have legalized the recreational use of the drug, should not be a top priority for federal law enforcement officials, President Obama told ABC News’ Barbara Walters.
Marijuana is a popular topic on the White House’s “We the People” online petition program, The Washington Post reports. Currently the second-most popular petition, with 66,000 signatures, asks President Obama to remove marijuana from the federal Controlled Substances Act.
New government guidelines recommend primary care doctors counsel children and teens not to start smoking. The U.S. Preventive Services Task Force concluded that prevention is more effective than trying to get youth to stop smoking once they’ve started.
A panel of experts assembled by the U.S. Food and Drug Administration voted against recommending approval of the painkiller Zohydro ER on Friday. The panel cited concerns over the potential for addiction.